Dr. Dennis Stone joined the Office for Technology Development in August, 1998, as the Vice President for Technology Development. He directs licensing operations as well as the biotechnology development initiative taking place at the University of Texas Southwestern Medical Center at Dallas and is a liaison with pharmaceutical and biotechnology companies interested in partnership with UT Southwestern scientists. In addition to his role in this office, he is also a professor of internal medicine, physiology, and biochemistry, and is also the holder of the NCH Corporation Chair in Molecular Transport. His research focuses on the molecular analysis of proton pumps that are involved in renal acidification, osteoporosis, and cancer.

In his role as Vice President for Technology, Dr. Stone and his team have increased annual revenues from $3.5 million to $12 million. In addition, the office for Technology Development has launched six start-up biotechnology companies that collectively have raised over $150 million in venture financing. Dr. Stone has served on the board of directors of Eliance Biotechnology, Inc., MacroGenics, Inc., and Reata Pharmaceuticals, Inc. In addition, he served as the chairman of the U.T. Regents’ Technology Transfer Commission and is a member of the board of the Texas Emerging Technology Fund’s Life Science Commercialization Center. Dr. Stone is member of STARTech Early Venture’s Mentor Program, and is the recipient of the Metroplex Technology Business Council’ Technology Titan Award.

Dr. Stone received his undergraduate training in the Plan II Program at The University of Texas at Austin. After completion of medical school at UT Southwestern Medical Center at Dallas, he received his housestaff training in internal medicine at Columbia Presbyterian Medical Center in New York City. Subsequently, he completed clinical and research fellowship training in Nephrology at UT Southwestern and Cornell University in Ithaca, NY and in 1984, joined the faculty at UT-Southwestern. He has been the recipient of a Searle Scholarship and Established Investigator of the American Heart Association, and is a member of the American Society for Clinical Investigation and the Association of American Physicians.